Interações de Dimenidrinato

Dimenidrinato (Dramamine), anti-histamínico, tem 299 interações documentadas nas bulas da FDA e nas fichas informativas que indexamos (graves: 81; moderadas: 173; leves: 43; casos em que uma bula relata não haver interação significativa: 2). Cada item abaixo cita a frase em que se baseia. Esta página de medicamento é um ponto de partida, não um veredito para a sua situação.

Interações segundo a bula

Interações graves (81)

  • AclidínioanticolinérgicoGrave

    Avoid administrations of TUDORZA PRESSAIR with other anticholinergic-containing drugs. (bula de Aclidínio, Interações medicamentosas)

  • ÁlcoolÁlcoolGrave

    Note: This product contains Benzyl Alcohol. (bula de Dimenidrinato, Contraindicações)

  • AlprazolambenzodiazepínicoGrave

    • Effects on Driving and Operating Machinery: Patients receiving • alprazolam XR should be cautioned against operating machinery or driving a motor vehicle, as well as avoiding concomitant use of alcohol and other central nervous system (CNS) depressant drugs. (bula de Alprazolam, Advertências e precauções)

  • Azelastina + fluticasonaanti-histamínicoGrave

    • Avoid concurrent use of alcohol or other central nervous system (CNS) depressants with azelastine hydrochloride and fluticasone propionate nasal spray because further decreased alertness and impairment of CNS performance may occur. (bula de Azelastina + fluticasona, Advertências e precauções)

  • Beladona + ópioopioideGrave

    …AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL EXPOSURE; NEONATAL OPIOD WITHDRAWAL SYNDROME; and RISKS FROM CONCOMITANT USE WITH ALCOHOL, BENZODIAZEPINES OR OTHER CNS DEPRESSANTS Addiction, Abuse, and Misuse Belladonna and opium suppositories expose patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to… (bula de Beladona + ópio, Advertência em caixa preta)

  • BuprenorfinaopioideGrave

    Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Buprenorfina, Advertência em caixa preta)

  • Concomitant use of opioids or a barbiturate with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Butalbital + ácido acetilsalicílico + cafeína + codeína, Advertência em caixa preta)

  • Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Butalbital + paracetamol + cafeína + codeína, Advertência em caixa preta)

  • ButorfanolopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Butorfanol, Advertência em caixa preta)

  • Carbinoxaminaanti-histamínicoGrave

    Avoid concurrent use of Carbinoxamine Maleate Extended-Release Oral Suspension with alcohol or other central nervous system depressants because additional impairment of central nervous system performance may occur. (bula de Carbinoxamina, Advertências e precauções)

  • Cetaminadepressor do SNCGrave

    Benzodiazepines, Opioid Analgesics, or other CNS Depressants : Concomitant use may result in profound sedation, respiratory depression, coma, or death. (bula de Cetamina, Interações medicamentosas)

  • Cetirizinaanti-histamínicoGrave

    Avoid concurrent use of QUZYTTIR with alcohol or other CNS depressants because additional reduction in alertness and additional impairment of CNS performance may occur. (bula de Cetirizina, Advertências e precauções)

  • Cetoconazolantifúngico azólicoGrave

    This may potentiate and prolong hypnotic and sedative effects, especially with repeated dosing or chronic administration of these agents. (bula de Cetoconazol, Contraindicações)

  • Ciclobenzaprinarelaxante muscularGrave

    Based on its structural similarity to TCAs, concomitant use of TONMYA with: MAO inhibitors may be life-threatening [see Contraindications (4) ] , Alcohol, barbiturates, and other CNS depressants may increase the risk of adverse reactions associated with these drugs, Tramadol may increase the seizure risk, Guanethidine or other similar acting drugs may block the… (bula de Ciclobenzaprina, Interações medicamentosas)

  • CiprofloxacinofluoroquinolonaGrave

    Table 8: Drugs That are Affected by and Affecting Ciprofloxacin Drugs That are Affected by Ciprofloxacin Drug(s) Recommendation Comments Tizanidine Contraindicated Concomitant administration of tizanidine and ciprofloxacin is contraindicated due to the potentiation of hypotensive and sedative effects of tizanidine [see Contraindications ( 4.2 )]. (bula de Ciprofloxacino, Interações medicamentosas)

  • Citrato de potássiosuplemento de potássioGrave

    In patients in whom there is cause for arrest or delay in tablet passage through the gastrointestinal tract, such as those suffering from delayed gastric emptying, esophageal compression, intestinal obstruction or stricture, or those taking anticholinergic medication. (bula de Citrato de potássio, Contraindicações)

  • Clonidinaagonista alfa-adrenérgicoGrave

    Avoid use with other central nervous system (CNS) depressants ( 5.3 ) (bula de Clonidina, Advertências e precauções)

  • ClozapinaantipsicóticoGrave

    When possible, avoid concomitant use, with other anticholinergic medications because the risk for anticholinergic toxicity or severe gastrointestinal adverse reactions is increased [see Warnings and Precautions ( 5.7 ), Drug Interactions ( 7.1 )]. (bula de Clozapina, Advertências e precauções)

  • CodeínaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Codeína, Advertência em caixa preta)

  • DarunavirantirretroviralGrave

    …elbasvir/grazoprevir Lipid modifying agents: lomitapide, lovastatin, simvastatin Opioid Antagonist: naloxegol PDE-5 inhibitor: sildenafil when used for treatment of pulmonary arterial hypertension Sedatives/hypnotics: orally administered midazolam, triazolam Co-administration of PREZISTA/ritonavir is contraindicated with drugs that are highly dependent on CYP3A for clearance… (bula de Darunavir, Contraindicações)

  • Darunavir + cobicistateantirretroviralGrave

    …elbasvir/grazoprevir Lipid modifying agents: lomitapide, lovastatin, simvastatin Opioid Antagonist: naloxegol PDE-5 inhibitor: sildenafil when used for treatment of pulmonary arterial hypertension Sedatives/hypnotics: orally administered midazolam, triazolam PREZCOBIX or PREZCOBIX PED is contraindicated in patients receiving certain co-administered drugs for which altered plasma… (bula de Darunavir + cobicistate, Contraindicações)

  • Difenidraminaanti-histamínicoGrave

    CONTRAINDICATIONS Neonates and patients with a history of hypersensitivity to dimenhydrinate or its components (diphenhydramine or 8-chlorotheophylline) should not be treated with dimenhydrinate. (bula de Dimenidrinato, Contraindicações)

  • CONTRAINDICATIONS Diphenoxylate hydrochloride and atropine sulfate is contraindicated in: • Pediatric patients less than 6 years of age due to the risks of respiratory and central nervous system (CNS) depression (see WARNINGS ). (bula de Difenoxilato + atropina, Contraindicações)

  • Usage of MOTOFEN ® in recommended doses is not likely to cause prominent anticholinergic side effects, but MOTOFEN ® should be avoided in patients in whom anticholinergic drugs are contraindicated. (bula de Difenoxina + atropina, Advertências)

  • Doxilaminaanti-histamínicoGrave

    …glaucoma • trouble urinating due to an enlarged prostate gland Ask a doctor or pharmacist before use if you are taking • a sedative or any other sleep-aid • tranquilizers • any other antihistamines • any other drugs When using this product • avoid alcoholic beverages • do not drive a motor vehicle or operate machinery • take only at bedtime Stop use and ask a doctor… (bula de Doxilamina, Advertências)

  • Doxilamina + piridoxinaanti-histamínicoGrave

    …hydrochloride delayed-release tablets are contraindicated in women with any of the following conditions: Known hypersensitivity to doxylamine succinate, other ethanolamine derivative antihistamines, pyridoxine hydrochloride or any inactive ingredient in the formulation Monoamine oxidase (MAO) inhibitors intensify and prolong the adverse central nervous system effects… (bula de Doxilamina + piridoxina, Contraindicações)

  • …Lipid-modifying Agents: lomitapide, lovastatin, simvastatin Phosphodiesterase-5 (PDE-5) Inhibitor: sildenafil when administered as REVATIO ® for the treatment of pulmonary arterial hypertension Sedative/hypnotics: triazolam, orally administered midazolam Coadministration of GENVOYA is contraindicated with drugs that: Are highly dependent on CYP3A for clearance and for which… (bula de Elvitegravir + cobicistate + entricitabina + tenofovir, Contraindicações)

  • Eszopiclonasedativo-hipnóticoGrave

    The use of LUNESTA with other sedative-hypnotics at bedtime or the middle of the night is not recommended. (bula de Eszopiclona, Advertências e precauções)

  • Fenelzinainibidor da MAOGrave

    Phenelzine sulfate should not be used in combination with dextromethorphan or with CNS depressants such as alcohol and certain narcotics. (bula de Fenelzina, Contraindicações)

  • FentanilaopioideGrave

    • Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Fentanila, Advertência em caixa preta)

  • FosamprenavirantirretroviralGrave

    …Hypericum perforatum ) Lipid modifying agents: Lomitapide, lovastatin, simvastatin Non-nucleoside reverse transcriptase inhibitor: Delavirdine PDE5 inhibitor: Sildenafil (Revatio) (for treatment of pulmonary arterial hypertension) Sedative/hypnotics: Midazolam, triazolam Hypersensitivity to fosamprenavir calcium or amprenavir (e.g., Stevens-Johnson syndrome). (bula de Fosamprenavir, Contraindicações)

  • GlicopirrônioanticolinérgicoGrave

    • Other Conditions Exacerbated by Anticholinergic Adverse Reactions : Use is not recommended in patients with autonomic neuropathy, hyperthyroidism, cardiac disease, hiatal hernia, etc. (bula de Glicopirrônio, Advertências e precauções)

  • Intervention Concomitant use of anticholinergic drugs with GVOKE VialDx is not recommended. (bula de Glucagon, Interações medicamentosas)

  • HidrocodonaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Hidrocodona, Advertência em caixa preta)

  • …ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; MEDICATION ERRORS; CYTOCHROME P450 3A4 INTERACTION; CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; INTERACTION WITH ALCOHOL; NEONATAL OPIOID WITHDRAWAL SYNDROME WARNING: ADDICTION, ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION;… (bula de Hidrocodona + clorfeniramina, Advertência em caixa preta)

  • …ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; MEDICATION ERRORS; CYTOCHROME P450 3A4 INTERACTION; CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; INTERACTION WITH ALCOHOL; NEONATAL OPIOID WITHDRAWAL SYNDROME Addiction, Abuse, and Misuse Hydrocodone bitartrate and homatropine methylbromide exposes patients and… (bula de Hidrocodona + homatropina, Advertência em caixa preta)

  • …LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; CYTOCHROME P4503A4 INTERACTION; RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; and SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF HYDROCODONE BITARTRATE AND IBUPROFEN TABLETS Addiction,… (bula de Hidrocodona + ibuprofeno, Advertência em caixa preta)

  • Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Hidrocodona + paracetamol, Advertência em caixa preta)

  • HidromorfonaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death . (bula de Hidromorfona, Advertência em caixa preta)

  • Hidroxizinaanti-histamínicoGrave

    Rarely, cardiac arrests and death have been reported in association with the combined use of hydroxyzine hydrochloride intramuscularly and other CNS depressants. (bula de Hidroxizina, Precauções)

  • IpratrópioanticolinérgicoGrave

    Avoid administration of ATROVENT HFA with other anticholinergic-containing drugs ( 7.1 ) (bula de Ipratrópio, Interações medicamentosas)

  • Levocetirizinaanti-histamínicoGrave

    Avoid concurrent use of alcohol or other central nervous system depressants with XYZAL. (bula de Levocetirizina, Advertências e precauções)

  • LevorfanolopioideGrave

    Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Levorfanol, Advertência em caixa preta)

  • Lopinavir + ritonavirantirretroviralGrave

    …Non-opioid Analgesic (selective blocker of Nav1.8 sodium channels): suzetrigine PDE5 Inhibitor: sildenafil (Revatio ® ) when used for the treatment of pulmonary arterial hypertension Sedative/Hypnotics: triazolam, orally administered midazolam KALETRA is contraindicated with drugs that are potent CYP3A inducers where significantly reduced lopinavir plasma concentrations… (bula de Lopinavir + ritonavir, Contraindicações)

  • LorazepambenzodiazepínicoGrave

    Caution patients receiving LOREEV XR against operating machinery or driving a motor vehicle as well to avoid the concomitant use of alcohol and other CNS depressant drugs during treatment ( 5.4 , 7 ) (bula de Lorazepam, Advertências e precauções)

  • MetadonaopioideGrave

    Managing Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, is a risk factor for respiratory depression and death [see Warnings and Precautions ( 5.2 )]. (bula de Metadona, Advertência em caixa preta)

  • Metaxalonarelaxante muscularGrave

    If concomitant use with another CNS depressant is warranted, closely monitor for signs of respiratory depression and sedation, particularly during treatment initiation and dosage increases. (bula de Metaxalona, Advertências e precauções)

  • Metoclopramidaantagonista da dopaminaGrave

    Other important considerations in the differential diagnosis include central anticholinergic toxicity, heat stroke, malignant hyperthermia, drug fever, serotonin syndrome, and primary central nervous system pathology. (bula de Metoclopramida, Advertências e precauções)

  • MidazolambenzodiazepínicoGrave

    WARNING: PERSONNEL AND EQUIPMENT FOR MONITORING AND RESUSCITATION AND RISKS FROM CONCOMITANT USE WITH OPIOID ANALGESICS AND OTHER SEDATIVE-HYPNOTICS Personnel and Equipment for Monitoring and Resuscitation Only personnel trained in the administration of procedural sedation, and not involved in the conduct of the diagnostic or therapeutic procedure, should administer… (bula de Midazolam, Advertência em caixa preta)

  • Moexiprilinibidor da ECAGrave

    None of the cases were considered life-threatening and all resolved either without treatment or with medication (antihistamines or glucocorticoids). (bula de Moexipril, Advertências)

  • MorfinaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Morfina, Advertência em caixa preta)

  • NalbufinaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Nalbufina, Advertência em caixa preta)

  • Nalmefenoantagonista opioideGrave

    Risk of Recurrent Respiratory and CNS Depression : A recurrence of respiratory depression is possible, therefore, keep the patient under continued surveillance and administer repeat doses of ZURNAI using a new auto-injector with each dose while awaiting emergency medical assistance. (bula de Nalmefeno, Advertências e precauções)

  • …(selective blocker of Na v 1.8 sodium channels): suzetrigine • Opioid antagonists: naloxegol • PDE5 inhibitor: sildenafil (Revatio ® ) when used for pulmonary arterial hypertension (PAH) • Sedative/hypnotics: triazolam, oral midazolam • Serotonin receptor 1A agonist/serotonin receptor 2A antagonist: flibanserin • Vasopressin receptor antagonists: tolvaptan ➢ Drugs that… (bula de Nirmatrelvir + ritonavir, Contraindicações)

  • OliceridinaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Oliceridina, Advertência em caixa preta)

  • Olopatadinaanti-histamínicoGrave

    • Avoid concurrent use of alcohol or other central nervous system depressants with olopatadine hydrochloride nasal solution (nasal spray) ( 5.2 ). (bula de Olopatadina, Advertências e precauções)

  • Olopatadina + mometasonaanti-histamínicoGrave

    • Avoid concurrent use of alcohol or other central nervous system (CNS) depressants with RYALTRIS because additional reductions in alertness and additional impairment of CNS performance may occur. (bula de Olopatadina + mometasona, Advertências e precauções)

  • Oxibato de sódiodepressor do SNCGrave

    Abuse or misuse of illicit GHB, either alone or in combination with other CNS depressants, is associated with CNS adverse reactions, including seizure, respiratory depression, decreases in the level of consciousness, coma, and death [see Warnings and Precautions ( 5.2 )]. (bula de Oxibato de sódio, Advertência em caixa preta)

  • OxicodonaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Oxicodona, Advertência em caixa preta)

  • …LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; CYTOCHROME P450 3A4 INTERACTION; and RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS Addiction, Abuse, and Misuse Oxycodone hydrochloride tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to… (bula de Oxicodona + paracetamol, Advertência em caixa preta)

  • OximorfonaopioideGrave

    Risks From Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Oximorfona, Advertência em caixa preta)

  • Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Paracetamol + codeína, Advertência em caixa preta)

  • …MITIGATION STRATEGY (REMS); LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; and RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS Addiction, Abuse, and Misuse Pentazocine and Naloxone Tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to… (bula de Pentazocina + naloxona, Advertência em caixa preta)

  • PerfenazinaantipsicóticoGrave

    …contraindicated in comatose or greatly obtunded patients and in patients receiving large doses of central nervous system depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines); in the presence of existing blood dyscrasias, bone marrow depression, or liver damage; and in patients who have shown hypersensitivity to perphenazine products, their… (bula de Perfenazina, Contraindicações)

  • Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Petidina (meperidina), Advertência em caixa preta)

  • Pitolisantomedicamento que prolonga o intervalo QTGrave

    Prevention or Management: Avoid centrally acting H1 receptor antagonists. (bula de Pitolisanto, Interações medicamentosas)

  • …PROMETHAZINE AND RESPIRATORY DEPRESSION IN CHILDREN; MEDICATION ERRORS; INTERACTIONS WITH DRUGS AFFECTING CYTOCHROME P450 ISOENZYMES; CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; NEONATAL OPIOID WITHDRAWAL SYNDROME Addiction, Abuse, and Misuse Promethazine HCl and Codeine Phosphate Oral Solution exposes patients and other users to the risks… (bula de Prometazina + codeína, Advertência em caixa preta)

  • QuinidinaantiarrítmicoGrave

    Quinidine is also contraindicated in patients who, like those with myasthenia gravis, might be adversely affected by an anticholinergic agent. (bula de Quinidina, Contraindicações)

  • RemifentanilaopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Remifentanila, Advertência em caixa preta)

  • RitonavirantirretroviralGrave

    WARNING: DRUG-DRUG INTERACTIONS LEADING TO POTENTIALLY SERIOUS AND/OR LIFE THREATENING REACTIONS Co-administration of NORVIR with several classes of drugs including sedative hypnotics, antiarrhythmics, or ergot alkaloid preparations may result in potentially serious and/or life-threatening adverse events due to possible effects of NORVIR on the hepatic metabolism… (bula de Ritonavir, Advertência em caixa preta)

  • Rivastigminainibidor da colinesteraseGrave

    Concomitant use with metoclopramide, beta-blockers, or cholinomimetic and anticholinergic drugs is not recommended ( 7.1 , 7.2 , 7.3 ) (bula de Rivastigmina, Interações medicamentosas)

  • TapentadolopioideGrave

    Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Tapentadol, Advertência em caixa preta)

  • TiotrópioanticolinérgicoGrave

    Avoid administration of SPIRIVA RESPIMAT with other anticholinergic-containing drugs. (bula de Tiotrópio, Interações medicamentosas)

  • TramadolopioideGrave

    Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Tramadol, Advertência em caixa preta)

  • Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. (bula de Tramadol + paracetamol, Advertência em caixa preta)

  • Tranilciprominainibidor da MAOGrave

    These medicines are in some cold, hay fever or weight-loss medicines. sympathomimetic herbal medicines or dietary supplements antihistamines (allergy medicines) triptans buspirone carbamazepine dextromethorphan dopamine hydroxytryptophan and tryptophan levodopa and methyldopa meperidine rasagline resperine s-adenosyl-L-methionine (SAM-e) tapentadol tetrabenazin… (bula de Tranilcipromina, Advertência em caixa preta)

  • TriazolambenzodiazepínicoGrave

    • Effects on Driving and Operating Heavy Machinery : Patients receiving triazolam should be cautioned against driving or operating heavy machinery, as well as avoiding concomitant use with alcohol and other CNS depressant drugs. (bula de Triazolam, Advertências e precauções)

  • UmeclidínioanticolinérgicoGrave

    Avoid administration of Umeclidinium ELLIPTA with other anticholinergic-containing drugs. (bula de Umeclidínio, Interações medicamentosas)

  • Umeclidínio + vilanterolanticolinérgicoGrave

    Avoid administration of Umeclidinium and Vilanterol ELLIPTA with other anticholinergic-containing drugs. (bula de Umeclidínio + vilanterol, Interações medicamentosas)

  • Zaleplonasedativo-hipnóticoGrave

    The use of zaleplon with other sedative-hypnotics at bedtime or the middle of the night is not recommended (see ). (bula de Zaleplona, Advertências)

  • Zolpidemsedativo-hipnóticoGrave

    The use of Zolpidem Tartrate with other sedative-hypnotics (including other zolpidem products) at bedtime or the middle of the night is not recommended. (bula de Zolpidem, Advertências e precauções)

Interações moderadas (173)

  • Ácido valproicoanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • AlentuzumabeimunossupressorModerada

    Premedicate patients with an antihistamine and acetaminophen prior to each dose. (bula de Alentuzumabe, Advertências e precauções)

  • Alisquirenoanti-hipertensivoModerada

    Patients who experience these effects, even without respiratory distress, require prolonged observation and appropriate monitoring measures since treatment with antihistamines and corticosteroids may not be sufficient to prevent respiratory involvement. (bula de Alisquireno, Advertências e precauções)

  • Alopurinolinibidor da xantina oxidaseModerada

    Inform patients also that the central nervous system depressant effects of allopurinol tablets may be additive to those of alcohol and other CNS depressants. (bula de Alopurinol, Advertências e precauções)

  • AlpelisibeModerada

    If a SCAR is not confirmed, VIJOICE may require dose modifications, topical or systemic corticosteroids, or oral antihistamine treatment as described in Table 4 [see Dosage and Administration (2.5)] . (bula de Alpelisibe, Advertências e precauções)

  • AminofilinametilxantinaModerada

    25% increase Diazepam Benzodiazepines increase CNS concentrations of adenosine, a potent CNS depressant, while theophylline blocks adenosine receptors. (bula de Aminofilina, Interações medicamentosas)

  • Amitriptilinaantidepressivo tricíclicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Amoxapinaantidepressivo tricíclicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • AripiprazolantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • AsenapinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Azelastinaanti-histamínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Baclofenorelaxante muscularModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Benazepril + hidroclorotiazidainibidor da ECAModerada

    Drugs that alter gastrointestinal motility: The bioavailability of thiazide-type diuretics may be increased by anticholinergic agents (e.g., atropine, biperiden), apparently due to a decrease in gastrointestinal motility and the stomach emptying rate. (bula de Benazepril + hidroclorotiazida, Interações medicamentosas)

  • BendamustinaModerada

    Consider measures to prevent severe reactions, including antihistamines, antipyretics and corticosteroids in subsequent cycles in patients who have experienced Grade 1 or 2 infusion reactions. (bula de Bendamustina, Advertências e precauções)

  • Sedatives/Hypnotics: midazolam (oral) triazolam ↑ midazolam (oral) ↑ triazolam Use caution when midazolam or triazolam is concomitantly administered with BIXLENVO. (bula de Bictegravir + entricitabina + tenofovir alafenamida, Interações medicamentosas)

  • BrexpiprazolantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Brimonidinaagonista alfa-adrenérgicoModerada

    Use with CNS depressants may result in an additive or potentiating effect. (bula de Brimonidina, Interações medicamentosas)

  • Brimonidina + timololagonista alfa-adrenérgicoModerada

    Use with CNS depressants may result in an additive or potentiating effect. (bula de Brimonidina + timolol, Interações medicamentosas)

  • BrivaracetamanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Budesonida + formoterolcorticosteroideModerada

    In clinical studies, concurrent administration of budesonide and formoterol fumarate dihydrate and other drugs, such as short-acting beta 2 -agonists, intranasal corticosteroids, and antihistamines/decongestants has not resulted in an increased frequency of adverse reactions. (bula de Budesonida + formoterol, Interações medicamentosas)

  • Bupivacaínaanestésico localModerada

    Possible early warning signs of central nervous system (CNS) toxicity are restlessness, anxiety, incoherent speech, lightheadedness, numbness and tingling of the mouth and lips, metallic taste, tinnitus, dizziness, blurred vision, tremors, twitching, CNS depression, or drowsiness. (bula de Bupivacaína, Advertências e precauções)

  • Bupivacaína + epinefrinaanestésico localModerada

    Possible early warning signs of central nervous system (CNS) toxicity are restlessness, anxiety, incoherent speech, lightheadedness, numbness and tingling of the mouth and lips, metallic taste, tinnitus, dizziness, blurred vision, tremors, twitching, CNS depression, or drowsiness. (bula de Bupivacaína + epinefrina, Advertências e precauções)

  • The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Buspironamedicamento serotoninérgicoModerada

    Triazolam/flurazepam: Coadministration of buspirone with either triazolam or flurazepam did not appear to prolong or intensify the sedative effects of either benzodiazepine. (bula de Buspirona, Interações medicamentosas)

  • The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Butalbital + paracetamolbarbitúricoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • CarbamazepinaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • CarbidopaModerada

    Other important considerations in the differential diagnosis include central anticholinergic toxicity, heat stroke, drug fever, and primary central nervous system (CNS) pathology. (bula de Carbidopa, Advertências)

  • CariprazinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Carisoprodolrelaxante muscularModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • CenobamatoanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Ciproeptadinaanti-histamínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Clemastinaanti-histamínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • ClobazambenzodiazepínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Clomipraminaantidepressivo tricíclicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • ClonazepambenzodiazepínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • ClorazepatobenzodiazepínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • ClordiazepóxidobenzodiazepínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Clordiazepóxido + clidíniobenzodiazepínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Clorfeniraminaanti-histamínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • ClorpromazinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Clorzoxazonarelaxante muscularModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Dantrolenorelaxante muscularModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Daridorexantosedativo-hipnóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • DarifenacinaanticolinérgicoModerada

    Darifenacin extended-release tablets, like other anticholinergic drugs, may decrease gastrointestinal motility and should be used with caution in patients with conditions such as severe constipation, ulcerative colitis, and myasthenia gravis. (bula de Darifenacina, Advertências e precauções)

  • Desfluranoanestésico geralModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Desipraminaantidepressivo tricíclicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Deutetrabenazinainibidor do VMAT2Moderada

    Other important considerations in the differential diagnosis include central anticholinergic toxicity, heat stroke, drug fever, and primary central nervous system pathology. (bula de Deutetrabenazina, Advertências e precauções)

  • Dexclorfeniraminaanti-histamínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Dexmedetomidinaagonista alfa-adrenérgicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Dextrometorfano + quinidinamedicamento serotoninérgicoModerada

    Anticholinergic effects of quinidine: Monitor for worsening in myasthenia gravis and other sensitive conditions. (bula de Dextrometorfano + quinidina, Advertências e precauções)

  • DiazepambenzodiazepínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • DicicloverinaanticolinérgicoModerada

    Anticholinergic agents: may affect the gastrointestinal absorption of various drugs; may also increase certain actions or side effects of other anticholinergic drugs (7) (bula de Dicicloverina, Interações medicamentosas)

  • Divalproato de sódio (valproato)anticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Doxepinaantidepressivo tricíclicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • DronabinolcanabinoideModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Droperidolantagonista da dopaminaModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • EfavirenzantirretroviralModerada

    Prophylaxis with appropriate antihistamines before initiating therapy with efavirenz in pediatric patients should be considered. (bula de Efavirenz, Advertências e precauções)

  • EluxadolinaopioideModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Epinefrina (adrenalina)simpaticomiméticoModerada

    …arrhythmias [see Warnings and Precautions (5.6) and Adverse Reactions (6) ]. β-blockers, such as propranolol Cyclopropane or halogenated hydrocarbon anesthetics, such as halothane Antihistamines Thyroid hormones Diuretics Cardiac glycosides, such as digitalis glycosides Quinidine Drugs potentiating hypokalemic effects of epinephrine • Potassium depleting diuretics… (bula de Epinefrina (adrenalina), Interações medicamentosas)

  • EscopolaminaanticolinérgicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • EslicarbazepinaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • EstazolambenzodiazepínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Etomidatoanestésico geralModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • EtossuximidaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • FelbamatoanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • FenitoínaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • FenobarbitalbarbitúricoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Fentermina + topiramatoestimulante do SNCModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • FesoterodinaanticolinérgicoModerada

    Urinary Retention in Adult Patients With Bladder Outlet Obstruction The use of Toviaz, like other antimuscarinic drugs, in patients with clinically significant bladder outlet obstruction, including patients with urinary retention, may result in further urinary retention and kidney injury. (bula de Fesoterodina, Advertências e precauções)

  • Flibanserinadepressor do SNCModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • FlufenazinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • FlumazenilbenzodiazepínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • FosfenitoínaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • GabapentinaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Guanfacinaagonista alfa-adrenérgicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • HaloperidolantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • • Large doses of salicylates, cortisone, adrenocorticotropic hormone (ACTH), estrogens or antihistamines may require larger amounts of hyaluronidase for equivalent dispersing effect ( 7.4 ) (bula de Hialuronidase, Interações medicamentosas)

  • IloperidonaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Imatinibeinibidor da CYP3A4Moderada

    In these instances, Gleevec was resumed at a dose lower than that at which the reaction occurred and some patients also received concomitant treatment with corticosteroids or antihistamines. (bula de Imatinibe, Advertências e precauções)

  • Imipraminaantidepressivo tricíclicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • InfliximabeimunossupressorModerada

    Medications for the treatment of hypersensitivity reactions (e.g., acetaminophen, antihistamines, corticosteroids and/or epinephrine) should be available for immediate use in the event of a reaction [see Dosage and Administration (2.10) and Adverse Reactions (6.1) ] . (bula de Infliximabe, Advertências e precauções)

  • Ipratrópio + salbutamolanticolinérgicoModerada

    Caution is, therefore, advised in the co-administration of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution with other drugs having anticholinergic properties. β-adrenergic agents Caution is advised in the co-administration of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution and other sympathomimetic agents due to the increased risk… (bula de Ipratrópio + salbutamol, Interações medicamentosas)

  • Isofluranoanestésico geralModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Isoprenalina (isoproterenol)agonista beta-adrenérgicoModerada

    Drugs that may potentiate clinical response of Isoproterenol Clinical Impact The effects of isoproterenol may be potentiated by tricyclic antidepressants, monoamine oxidase inhibitors, levothyroxine sodium, and certain antihistamines, notably chlorpheniramine, tripelennamine, and diphenhydramine. (bula de Isoprenalina (isoproterenol), Interações medicamentosas)

  • LacosamidaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Lemborexantosedativo-hipnóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • LevetiracetamanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Lidocaína + epinefrinaanestésico localModerada

    Possible early warning signs of central nervous system (CNS) toxicity are restlessness, anxiety, incoherent speech, lightheadedness, metallic taste, tinnitus, dizziness, blurred vision, tremors, twitching, CNS depression, or drowsiness. (bula de Lidocaína + epinefrina, Advertências e precauções)

  • Lisinopril + hidroclorotiazidainibidor da ECAModerada

    Even in those instances where swelling of only the tongue is involved, without respiratory distress, patients may require prolonged observation since treatment with antihistamines and corticosteroids may not be sufficient. (bula de Lisinopril + hidroclorotiazida, Advertências)

  • Lofexidinaagonista alfa-adrenérgicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • LoxapinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • LumateperonaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • LurasidonaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • In patients who experience mild or moderate IRRs, consider premedications, including antihistamines, corticosteroids, and antipyretics. (bula de Margetuximabe, Advertências e precauções)

  • Meclizinaanti-histamínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • MefloquinaantimaláricoModerada

    Other Drugs that Prolong the QTc Interval Coadministration of other drugs known to alter cardiac conduction (e.g., anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H 1 -blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval. (bula de Mefloquina, Interações medicamentosas)

  • Meprobamatodepressor do SNCModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Mesuximida (metossuximida)anticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • MetirosinaModerada

    Concurrent use of metyrosine with alcohol or other CNS depressants can increase their sedative effects. (bula de Metirosina, Interações medicamentosas)

  • Metocarbamolrelaxante muscularModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • MetoexitalbarbitúricoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Mirabegronaagonista beta-adrenérgicoModerada

    • Urinary Retention in Patients With Bladder Outlet Obstruction and in Patients Taking Muscarinic Antagonist Drugs for Overactive Bladder : Administer with caution in these patients because of risk of urinary retention. (bula de Mirabegrona, Advertências e precauções)

  • MirtazapinaantidepressivoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Anaphylactic Shock and Hypersensitivity Reactions: Premedicate all patients with a combination of an H1-antihistamine, an H2 blocker, and a leukotriene inhibitor prior to each APHEXDA dose. (bula de Motixafortida, Advertências e precauções)

  • Naloxonaantagonista opioideModerada

    WARNINGS AND PRECAUTIONS Risk of Recurrent Respiratory and CNS Depression : Due to the duration of action of naloxone relative to the opioid, respiratory and CNS depression may recur after the first dose of naloxone. (bula de Naloxona, Advertências e precauções)

  • Naltrexona + bupropionaantagonista opioideModerada

    …malformation, central nervous system tumor or infection, or metabolic disorders (e.g., hypoglycemia, hyponatremia, severe hepatic impairment, and hypoxia) excessive use of alcohol or sedatives, addiction to cocaine or stimulants, or withdrawal from sedatives patients with diabetes treated with insulin and/or oral diabetic medications (sulfonylureas and meglitinides)… (bula de Naltrexona + bupropiona, Advertências e precauções)

  • Neostigminainibidor da colinesteraseModerada

    An anticholinergic agent, (e.g., atropine sulfate or glycopyrrolate) should be administered prior to Neostigmine Methylsulfate Injection administration to lessen the risk of bradycardia [ see Dosage and Administration ( 2.4 ) ]. (bula de Neostigmina, Advertências e precauções)

  • Nortriptilinaantidepressivo tricíclicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • OcrelizumabeimunossupressorModerada

    In multiple sclerosis (MS) clinical trials, all adult and pediatric patients who were treated with OCREVUS received premedication with methylprednisolone (or an equivalent steroid), and may have also received an antihistamine (all pediatric patients) and/or an analgesic/antipyretic to reduce the risk of infusion reactions prior to each infusion. (bula de Ocrelizumabe, Advertências e precauções)

  • OfloxacinofluoroquinolonaModerada

    Serious acute hypersensitivity reactions may require treatment with epinephrine and other resuscitative measures, including oxygen, intravenous fluids, antihistamines, corticosteroids, pressor amines, and airway management, as clinically indicated (see PRECAUTIONS and ADVERSE REACTIONS ). (bula de Ofloxacino, Advertências)

  • OlanzapinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Olanzapina + fluoxetinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Orfenadrinarelaxante muscularModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • OxazepambenzodiazepínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • OxcarbazepinaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • OxibutininaanticolinérgicoModerada

    Oxybutynin chloride extended-release tablets, like other anticholinergic drugs, may decrease gastrointestinal motility and should be used with caution in patients with conditions such as ulcerative colitis and intestinal atony. (bula de Oxibutinina, Advertências e precauções)

  • PaliperidonaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • PerampanelanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Pilocarpinaagonista colinérgicoModerada

    These effects should be considered when anticholinergic properties may be contributing to the therapeutic effect of concomitant medication (e.g., atropine, inhaled ipratropium). (bula de Pilocarpina, Interações medicamentosas)

  • PimozidaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Piridostigminainibidor da colinesteraseModerada

    Use with caution in persons with increased risk of anticholinergic reactions, such as persons with bronchial asthma, chronic obstructive pulmonary disease, bradycardia, cardiac arrhythmias, beta blocker treatment (increased risk of anticholinergic reactions). (bula de Piridostigmina, Advertências e precauções)

  • Posaconazolantifúngico azólicoModerada

    Concomitant Use with Midazolam : Noxafil can prolong hypnotic/sedative effects. (bula de Posaconazol, Advertências e precauções)

  • Pramipexolagonista da dopaminaModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • PregabalinaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • PrimidonaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • ProcainamidaantiarrítmicoModerada

    Anticholinergic drugs administered concurrently with PA may produce additive antivagal effects on A-V nodal conduction, although this is not as well documented for PA as for quinidine. (bula de Procainamida, Interações medicamentosas)

  • ProclorperazinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Prometazinaanti-histamínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Prometazina + dextrometorfanoanti-histamínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Propofoldepressor do SNCModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Protriptilinaantidepressivo tricíclicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • QuetiapinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Ramelteonasedativo-hipnóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • RisperidonaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Ropinirolagonista da dopaminaModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • RufinamidaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Sevofluranoanestésico geralModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • SolifenacinaanticolinérgicoModerada

    Urinary Retention The use of Solifenacin succinate tablets, like other antimuscarinic drugs, in patients with clinically significant bladder outlet obstruction including patients with urinary retention, may result in further urinary retention and kidney injury. (bula de Solifenacina, Advertências e precauções)

  • SugamadexModerada

    Monitor for hemodynamic changes and administer anticholinergic agents such as atropine if clinically significant bradycardia is observed. (bula de Sugamadex, Advertências e precauções)

  • Suvorexantosedativo-hipnóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Suxametônio (succinilcolina)bloqueador neuromuscularModerada

    Pretreatment with anticholinergic agents (e.g., atropine) may reduce the occurrence of bradyarrhythmias. (bula de Suxametônio (succinilcolina), Advertências e precauções)

  • Tasimelteonasedativo-hipnóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • TemazepambenzodiazepínicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • TensirolimoModerada

    TORISEL should be used with caution in patients with known hypersensitivity to an antihistamine, or patients who cannot receive an antihistamine for other medical reasons. (bula de Tensirolimo, Advertências e precauções)

  • TeofilinametilxantinaModerada

    25% increase Diazepam Benzodiazepines increase CNS concentrations of adenosine, a potent CNS depressant, while theophylline blocks adenosine receptors. (bula de Teofilina, Interações medicamentosas)

  • Tetrabenazinainibidor do VMAT2Moderada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • TiagabinaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • TioridazinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • TiotixenoantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Tizanidinarelaxante muscularModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • TopiramatoanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Toxina botulínica tipo Abloqueador neuromuscularModerada

    Aminoglycosides or other agents interfering with neuromuscular transmission Anticholinergic drugs Botulinum neurotoxin products Muscle relaxants Aminoglycoside antibiotics, anticholinergic agents, or any other agents that interfere with neuromuscular transmission may potentiate the effect of DAXXIFY; co-administer only with caution and close observation. (bula de Toxina botulínica tipo A, Interações medicamentosas)

  • Toxina incobotulínica Abloqueador neuromuscularModerada

    Because of its anticholinergic effects, XEOMIN should be used with caution in patients at risk of developing narrow angle glaucoma. (bula de Toxina incobotulínica A, Advertências e precauções)

  • Toxina onabotulínica Abloqueador neuromuscularModerada

    Anticholinergic Drugs Use of anticholinergic drugs after administration of BOTOX may potentiate systemic anticholinergic effects. (bula de Toxina onabotulínica A, Interações medicamentosas)

  • TrazodonaantidepressivoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • TriexifenidilanticolinérgicoModerada

    Concurrent use of alcohol or other CNS depressants with trihexyphenidyl may cause increased sedative effects. (bula de Triexifenidil, Interações medicamentosas)

  • TrifluoperazinaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • The recent use of other drugs that cause CNS depression or EPS symptoms may also increase the risk; consider reducing the dosage or discontinuing the drug. (bula de Trimetobenzamida, Advertências e precauções)

  • Trimipraminaantidepressivo tricíclicoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • TróspioanticolinérgicoModerada

    Trospium chloride extended-release capsules, like other antimuscarinic agents, may decrease gastrointestinal motility and should be used with caution in patients with conditions such as ulcerative colitis, intestinal atony and myasthenia gravis. (bula de Tróspio, Advertências e precauções)

  • Valbenazinainibidor do VMAT2Moderada

    Other important considerations in the differential diagnosis include central anticholinergic toxicity, heat stroke, drug fever, and primary central nervous system pathology. (bula de Valbenazina, Advertências e precauções)

  • Vibegronaagonista beta-adrenérgicoModerada

    Urinary Retention : Monitor for urinary retention, especially in patients with bladder outlet obstruction and also in patients taking muscarinic antagonist medications for OAB, in whom the risk of urinary retention may be greater. (bula de Vibegrona, Advertências e precauções)

  • VigabatrinaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • Voriconazolantifúngico azólicoModerada

    Eszopiclone (CYP3A4 Inhibition) Not Studied In Vivo or In Vitro , but Drug Plasma Exposure Likely to be Increased which may Increase the Sedative Effect of Eszopiclone Dose reduction of eszopiclone is recommended. (bula de Voriconazol, Interações medicamentosas)

  • Prior to the first BIZENGRI infusion, premedicate with a corticosteroid, an H1 antihistamine and acetaminophen to reduce the risk of IRRs [see Dosage and Administration (2.4) ]. (bula de Zenocutuzumabe, Advertências e precauções)

  • ZiprasidonaantipsicóticoModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

  • ZonisamidaanticonvulsivanteModerada

    The concomitant use of alcohol or other central nervous system depressants may have an additive effect. (bula de Dimenidrinato, Advertências)

Menções leves (43)

  • The “gasping syndrome” is characterized by central nervous system (CNS) depression, metabolic acidosis, and gasping respirations. (bula de Alfaepoetina, Advertências e precauções)

  • If signs of hypersensitivity occur, e.g. anaphylactoid reaction or angioedema develops, discontinue the Activase infusion and promptly institute appropriate therapy (e.g., antihistamines, intravenous corticosteroids, epinephrine). (bula de Alteplase, Advertências e precauções)

  • Benazeprilinibidor da ECALeve

    Symptoms have not been relieved by antihistamines in these situations. (bula de Benazepril, Advertências e precauções)

  • BenzatropinaanticolinérgicoLeve

    When benztropine mesylate is given concomitantly with phenothiazines, haloperidol, or other drugs with anticholinergic or antidopaminergic activity, patients should be advised to report gastrointestinal complaints, fever or heat intolerance promptly. (bula de Benzatropina, Advertências)

  • Discontinue in patients who develop a severe infusion-related reaction and administer appropriate medical therapy (e.g., epinephrine, corticosteroids, intravenous antihistamines, bronchodilators and/or oxygen). (bula de Bevacizumabe, Advertências e precauções)

  • BupropionaantidepressivoLeve

    Additional predisposing conditions include diabetes mellitus treated with oral hypoglycemic drugs or insulin, use of anorectic drugs, excessive use of alcohol, use of benzodiazepines, sedatives/hypnotics, or opiates. (bula de Bupropiona, Advertências e precauções)

  • CefaclorcefalosporinaLeve

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (bula de Cefaclor, Advertências)

  • CefadroxilacefalosporinaLeve

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (bula de Cefadroxila, Advertências e precauções)

  • CefdinircefalosporinaLeve

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (bula de Cefdinir, Advertências)

  • CefotetanacefalosporinaLeve

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (bula de Cefotetana, Advertências)

  • CefpodoximacefalosporinaLeve

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINE, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (bula de Cefpodoxima, Advertências)

  • CefprozilacefalosporinaLeve

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, INTRAVENOUS FLUIDS, INTRAVENOUS ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (bula de Cefprozila, Advertências)

  • CeftazidimacefalosporinaLeve

    SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE TREATMENT WITH EPINEPHRINE AND OTHER EMERGENCY MEASURES, INCLUDING OXYGEN, IV FLUIDS, IV ANTIHISTAMINES, CORTICOSTEROIDS, PRESSOR AMINES, AND AIRWAY MANAGEMENT, AS CLINICALLY INDICATED. (bula de Ceftazidima, Advertências)

  • CeftriaxonacefalosporinaLeve

    Serious acute hypersensitivity reactions may require treatment with epinephrine and other emergency measures including oxygen, corticosteroids, intravenous fluids, intravenous antihistamines, pressor amines, and airway management, as clinically indicated. (bula de Ceftriaxona, Advertências e precauções)

  • Cevimelinaagonista colinérgicoLeve

    Cevimeline might interfere with desirable antimuscarinic effects of drugs used concomitantly. (bula de Cevimelina, Interações medicamentosas)

  • Dextroanfetaminaestimulante do SNCLeve

    Antihistamines Amphetamines may counteract the sedative effect of antihistamines. (bula de Dextroanfetamina, Interações medicamentosas)

  • Donepezilainibidor da colinesteraseLeve

    Cholinesterase inhibitors have the potential to interfere with the activity of anticholinergic medications ( 7.1 ) (bula de Donepezila, Interações medicamentosas)

  • In Drug-Induced CNS and Respiratory Depression Doxapram alone may not stimulate adequate spontaneous breathing or provide sufficient arousal in patients who are severely depressed either due to respiratory failure or to CNS depressant drugs, but may be used as an adjunct to established supportive measures and resuscitative techniques. (bula de Doxapram, Advertências)

  • Appropriate antihistamines and/or corticosteroids may improve the tolerability and hasten the resolution of rash. (bula de Efavirenz + lamivudina + tenofovir, Advertências e precauções)

  • Enalaprilinibidor da ECALeve

    Symptoms have not been relieved by antihistamines in these situations. (bula de Enalapril, Advertências e precauções)

  • In instances where swelling has been confined to the face and lips the condition has generally resolved without treatment, although antihistamines have been useful in relieving symptoms. (bula de Enalapril + hidroclorotiazida, Advertências)

  • Enalaprilateinibidor da ECALeve

    In instances where swelling has been confined to the face and lips the condition has generally resolved without treatment, although antihistamines have been useful in relieving symptoms. (bula de Enalaprilate, Advertências)

  • Eritromicinaantibiótico macrolídeoLeve

    Erythromycin has been reported to significantly alter the metabolism of the nonsedating antihistamines terfenadine and astemizole when taken concomitantly. (bula de Eritromicina, Interações medicamentosas)

  • FlunisolidacorticosteroideLeve

    Instead, nasal vasoconstrictors or oral antihistamines may be needed until the effects of flunisolide are fully manifested. (bula de Flunisolida, Precauções)

  • FluoxetinaISRSLeve

    Most patients improved promptly with discontinuation of fluoxetine and/or adjunctive treatment with antihistamines or steroids, and all patients experiencing these reactions were reported to recover completely. (bula de Fluoxetina, Advertências e precauções)

  • Galantaminainibidor da colinesteraseLeve

    Potential to interfere with the activity of anticholinergic medications ( 7.1 ) (bula de Galantamina, Interações medicamentosas)

  • HeparinaanticoagulanteLeve

    Other Interactions Digitalis, tetracyclines, nicotine, or antihistamines, or intravenous nitroglycerin may partially counteract the anticoagulant action of heparin sodium. (bula de Heparina, Interações medicamentosas)

  • Antihistamines and/or aspirin have been used for most mild to moderate cases. (bula de Ivermectina, Advertências)

  • LevofloxacinofluoroquinolonaLeve

    Serious acute hypersensitivity reactions may require treatment with epinephrine and other resuscitative measures, including oxygen, intravenous fluids, antihistamines, corticosteroids, pressor amines, and airway management, as clinically indicated [see Adverse Reactions ( 6 ) and Patient Counseling Information ( 17 )] . (bula de Levofloxacino, Advertências e precauções)

  • Lisinoprilinibidor da ECALeve

    Symptoms have not been relieved by antihistamines in these situations. (bula de Lisinopril, Advertências e precauções)

  • The infusion should be terminated immediately, followed by the administration of volume expanders, pressor agents, corticosteroids, or antihistamines at the discretion of the physician. (bula de Melfalana, Advertências)

  • Memantina + donepezilainibidor da colinesteraseLeve

    NAMZARIC may interfere with anticholinergic medications. (bula de Memantina + donepezila, Interações medicamentosas)

  • Oxacilinaantibiótico da classe das penicilinasLeve

    If an allergic reaction occurs, the drug should be discontinued and the patient should receive supportive treatment, e.g. , artificial maintenance of ventilation, pressor amines, antihistamines, and corticosteroids. (bula de Oxacilina, Advertências)

  • Pruritus and early rash may often be controlled by the concomitant administration of antihistamines. (bula de Penicilamina, Precauções)

  • PrazosinaalfabloqueadorLeve

    …to date with the following: (1) cardiac glycosides– digitalis and digoxin; (2) hypoglycemics–insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; (3) tranquilizers and sedatives–chlordiazepoxide, diazepam, and phenobarbital; (4) antigout–allopurinol, colchicine, and probenecid; (5) antiarrhythmics–procainamide, propranolol (see WARNINGS however),… (bula de Prazosina, Interações medicamentosas)

  • Quinaprilinibidor da ECALeve

    In instances where swelling is confined to the face and lips, the condition generally resolves without treatment; antihistamines may be useful in relieving symptoms. (bula de Quinapril, Advertências)

  • In instances where swelling is confined to the face and lips, the condition generally resolves without treatment; antihistamines may be useful in relieving symptoms. (bula de Quinapril + hidroclorotiazida, Advertências)

  • RituximabeimunossupressorLeve

    Premedicate patients with an antihistamine and acetaminophen prior to dosing. (bula de Rituximabe, Advertências e precauções)

  • Sacubitril + valsartanabloqueador do receptor da angiotensina II (BRA)Leve

    In cases of confirmed angioedema where swelling has been confined to the face and lips, the condition has generally resolved without treatment, although antihistamines have been useful in relieving symptoms. (bula de Sacubitril + valsartana, Advertências e precauções)

  • If symptoms of hypersensitivity occur, initiate appropriate therapy (e.g., antihistamines, corticosteroids, epinephrine). (bula de Tenecteplase, Advertências e precauções)

  • It is difficult to determine if Tolcapone tablets played a role in the pathogenesis of these events because these patients received several concomitant medications affecting the central nervous system such as monoaminergic (i.e., MAO-I, tricyclic and selective serotonin reuptake inhibitors) and anticholinergic agents. (bula de Tolcapona, Precauções)

  • Trandolaprilinibidor da ECALeve

    In instances where swelling is confined to the face and lips, the condition generally resolves without treatment; antihistamines may be useful in relieving symptoms. (bula de Trandolapril, Advertências)

  • Prior to resumption of trastuzumab infusion, the majority of patients who experienced a severe infusion reaction were pre-medicated with antihistamines and/or corticosteroids. (bula de Trastuzumabe, Advertências e precauções)

Nenhuma interação significativa relatada (2)

  • LenacapavirantirretroviralSem interação

    Sedatives/Hypnotics: midazolam (oral) triazolam ↑ midazolam (oral) ↑ triazolam Use with caution when midazolam or triazolam is concomitantly administered with SUNLENCA 7.4 Drugs without Clinically Significant Interactions with SUNLENCA Based on drug interaction studies conducted with SUNLENCA, no clinically significant drug interactions have been observed with:… (bula de Lenacapavir, Interações medicamentosas)

  • Montelucasteantagonista do receptor de leucotrienosSem interação

    …adjustment is needed when SINGULAIR is co-administered with theophylline, prednisone, prednisolone, oral contraceptives, fexofenadine, digoxin, warfarin, gemfibrozil, itraconazole, thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines, decongestants, and Cytochrome P450 (CYP) enzyme inducers [see Clinical Pharmacology (12.3) ]. (bula de Montelucaste, Interações medicamentosas)

Verifique Dimenidrinato com tudo o que você toma. Adicione sua lista completa; todos os pares são verificados de uma vez.

Abrir no verificador

Não é aconselhamento médico. A gravidade reflete a redação da bula, não as suas circunstâncias. Um alerta “grave” pode ser rotina sob supervisão, e um “leve” pode ser importante em doses altas. Pergunte a um farmacêutico.